Bellerophon Therapeutics, Inc. — Form D

Bellerophon Therapeutics, Inc. of WARREN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-21. The offering totals $1, of which $1 was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (41)

Showing 25 of 41 people.

NameRoleLocation
Bryan RobertsDirectorBoulder, CO
Daniel TasseExecutive OfficerChatillon, I0
Adam WeinsteinDirectorNew York, NY
Adam B WeinsteinDirectorNew York, NY
David AbramsExecutive OfficerTORONTO, A6
MATTHEW HOLTDirectorPalm Beach, FL
Daniel TasseDirectorChatillon, I0
Andre MouraDirectorNEW YORK, NY
Robert NelsenDirectorSeattle, WA
Howard PienDirectorHarrison, NY
Andre V MouraDirectorNew York, NY
Parag ShahExecutive OfficerBoston, MA
JONATHAN PEACOCKDirectorLONDON, X0
JONATHAN PEACOCKExecutive OfficerLONDON, X0
Jens P LuehringDirectorWarren, NJ
Mary Ann P CloydDirectorWarren, NJ
Martin A DekkerExecutive OfficerWarren, NJ
Deborah A QuinnExecutive OfficerWarren, NJ
Amy A EdmondsExecutive OfficerWarren, NJ
Scott P BruderDirectorWarren, NJ
Peter B FernandesExecutive OfficerWarren, NJ
Parag A ShahExecutive OfficerWarren, NJ
Daniel V TasseDirectorWarren, NJ
Naseem P AminDirectorWarren, NJ
Megan A SchoepsExecutive OfficerWarren, NJ

Other filings by this issuer (3)

FiledFormOfferingSold
2017-10-11D$23.4M$23.4M
2017-05-19D$1.6M$1.6M
2014-07-02D$1$1

More